Article 3 Amendment of articles 3 and 4 of, and Schedule 1 to, the principal Order

(1)

In article 3(1)(a) of the principal Order (medicinal products on prescription only), after the words “subject to article 4(1)” there are inserted the words “and (1A), and Part IV of Schedule 1”.

(2)

In article 4 of the principal Order (medicinal products that are not prescription only), after paragraph (1) there is inserted the following paragraph—

“(1A)

Notwithstanding article 3(1)(a), medicinal products specified in Part IV of Schedule 1 shall not be prescription only medicines.”

(3)

In Part I of Schedule 1 to the principal Order (which lists substances which render a medicinal product a prescription only medicine except in circumstances also listed)—

(a)

there are inserted in column 1, at the appropriate point in the alphabetical order of the substances listed, the substances specified in column 1 of Schedule 1 to this Order and in columns 2 and 3, so as to appear against the particular substance to which it relates, there is inserted as the case may be any entry appearing in columns 2 and 3 of Schedule 1 to this Order against that substance;

(b)

there are deleted from column 1 the substances specified in Schedule 2 to this Order;

(c)

for the entry in columns 2 and 3 relating to the substance Podophyllum Resin listed in column 1 there is substituted the entry relating to that substance set out in columns 2 and 3 of Schedule 3 to this Order;

(d)

(i)

in the footnote to the column 4 entries relating to the substances Atropine, Atropine Methobromide, Atropine Methonitrate, Atropine Oxide Hydrochloride, Atropine Sulphate, Hyoscine Butylbromide, Hyoscine Hydrobromide, Hyoscine Methobromide, Hyoscine Methonitrate, Hyoscyamine, Hyoscyamine Hydrobromide and Hyoscyamine Sulphate, after the words, “Subject to” there are inserted the words, “paragraph 1 of”; and

(ii)

in column 2 opposite each of the substances Sodium Fluoride, Sodium Monofluorophosphate and Stannous Fluoride there is inserted “(b)” and at the foot of each page where such an insertion is made there are inserted the words, “(b) Subject to paragraph 2 of the note at the end of Part I of Schedule 1.”; and

(iii)

after the word “Note:” where it appears at the end of that Part there is inserted the number “1.” and after the entry for the Note numbered 1. there is inserted the following new paragraph:

“2

In relation to a medicinal product which contains more than one of the substances Sodium Fluoride, Sodium Monofluorophosphate and Stannous Fluoride combined in a dentifrice, the maximum strength of the combination for the purposes of column 2 shall not exceed 0.15 per cent calculated as Fluorine.”

(4)

In Part III of Schedule 1 to the principal Order (medicinal products, specified by name and product licence number, which are prescription only medicines) there is deleted the entry “Debrisan 0009/0021”.

(5)

After Part III of Schedule 1 to the principal Order there is added Part IV as set out in Schedule 4 to this Order.